Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

587 Articles

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Dec 7, 2015 at 4:09 PM EST

Jefferies Top Pharma Stock Picks for 2016

Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.

Lee Jackson | Dec 4, 2015 at 9:55 AM EST

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

The Franchise Picks list makes sense for solid growth investors looking for total return. Many of the stocks pay good…

Jon C. Ogg | Dec 1, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia and Rackspace.

Lee Jackson | Nov 30, 2015 at 9:55 AM EST

Jefferies Has 4 Blue Chip High-Dividend Franchise Picks to Buy Now

Buying high-yielding blue chips for 2016 makes good sense. The Federal Reserve interest rate increases over the next two years…

Jon C. Ogg | Nov 24, 2015 at 9:54 AM EST

9 Stocks to Avoid in December and Beyond

You may want to avoid these stocks over the next few months.

Chris Lange | Nov 18, 2015 at 9:10 AM EST

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Lee Jackson | Nov 10, 2015 at 10:35 AM EST

Top Technology Stock Removed From Jefferies Franchise Picks List

Buying stocks such as these, with solid growth potential and paying dividends higher than the 10-year Treasury debt, makes good…

Jon C. Ogg | Nov 10, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods and Walt Disney.

Chris Lange | Oct 30, 2015 at 8:40 AM EDT

AbbVie Soars on Solid Earnings and Guidance

AbbVie reported better-than-expected third-quarter financial results before the markets opened on Friday.

Chris Lange | Oct 29, 2015 at 12:25 PM EDT

What to Look For in AbbVie Earnings

AbbVie is expected to report its third-quarter financial results before the markets open on Friday.

Chris Lange | Oct 27, 2015 at 12:55 PM EDT

What to Look For in Gilead Earnings

Gilead Sciences is set to report its third-quarter financial results after the markets close on Thursday.

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Oct 27, 2015 at 8:55 AM EDT

4 Top Jefferies Value Stocks to Buy This Week

Each week we cover the new value calls from the analysts at Jefferies, and more and more, some of the…

1 … 31 32 33 34 35 … 40

AbbVie : ABBV

All AbbVie Articles

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

Jefferies Has 4 Blue Chip High-Dividend Franchise Picks to Buy Now

9 Stocks to Avoid in December and Beyond

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Short Sellers Continue to Decrease Bets in Major Pharma

Top Technology Stock Removed From Jefferies Franchise Picks List

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

AbbVie Soars on Solid Earnings and Guidance

What to Look For in AbbVie Earnings

What to Look For in Gilead Earnings

Short Sellers Have Mixed Views on Major Pharma

4 Top Jefferies Value Stocks to Buy This Week

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

AbbVie : ABBV

All AbbVie Articles

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Jefferies Makes Year-End Changes to Franchise List of Stocks to Buy

Top Analyst Upgrades and Downgrades: AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia, Rackspace and Many More

Jefferies Has 4 Blue Chip High-Dividend Franchise Picks to Buy Now

9 Stocks to Avoid in December and Beyond

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Short Sellers Continue to Decrease Bets in Major Pharma

Top Technology Stock Removed From Jefferies Franchise Picks List

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

AbbVie Soars on Solid Earnings and Guidance

What to Look For in AbbVie Earnings

What to Look For in Gilead Earnings

Short Sellers Have Mixed Views on Major Pharma

4 Top Jefferies Value Stocks to Buy This Week

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Featured Reads

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves